Bayer Animal Health
P.O. Box 390
12 articles with Bayer Animal Health
nded team will enhance Elanco’s customer focus, expertise and agility as a dedicated animal health company
Bayer Animal Health announces the launch of Coraxis™ (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs.
8/16/2018BioNTech, headquartered in Mainz, Germany, and Pfizer, based in New York City, signed a multi-year research-and-development deal to develop mRNA-based flu vaccines.
A look at whether big money and big deals will be in store for 2018.
Bayer Animal Health and the American Association of Feline Practitioners Partner to Improve the Health of America's Cats
Bayer Animal Health Release: More Than 3,000 Veterinarian Views of the Latest Insights Into Canine Vector Borne Diseases Management
Groundbreaking Study Showed Bayer Animal Health's Advantage Multi(R) for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
Oculus Innovative Sciences, Inc. Development Partner, Bayer Animal Health, Receives Regulatory Approvals to Market Microcyn(R)-Based Vetericyn(TM) Animal Healthcare Products in China and Taiwan